Category health

5th December, 2024: Redcliffe Labs, a purpose-driven pan-India omnichannel diagnostics service provider, has conducted a study that reveals arthritis is no longer limited to older adults. It affects individuals of all age groups and genders. Conducted over three years with 2 million tests, it revealed that approximately 1 in 5 people are at risk of developing arthritis.

Arthritis symptoms often worsen during the winter season. Colder temperatures can increase joint stiffness and inflammation, making timely intervention even more critical. Individuals with arthritis are advised to adopt preventive measures such as regular physical activity and joint care. With India witnessing a remarkable rise in preventive healthcare awareness, the number of individuals seeking regular health checkups increasing by over threefold from 2022 to 2024. This growing focus on early detection is a critical step toward better health outcomes for millions. With a focus on increasing awareness about the health issue, Redcliffe Labs’ study highlights the gender-neutral nature of arthritis.

The study found abnormal test results in 18% of men and 10% of women aged 26 to 40. It indicates that arthritis is not exclusive to women; instead, the onset of arthritis is higher in men at a younger age, whereas the abnormalities are higher in women with increasing age. Both men and women should be equally cautious and proactive about their health, particularly during colder months.

Dr. Geetanjali Gupta, Director of Technical Operations and Quality Assurance at Redcliffe Labs, stated, “We are observing a shift in the demographics affected by arthritis. With 1 in 5 people at risk of developing arthritis, especially in the younger age group, early diagnosis becomes crucial in preserving mobility and quality of life. Identifying the condition in its early stages allows for proactive treatment, lifestyle adjustments, and long-term management that can significantly slow its progression and reduce its impact. It is crucial to raise awareness and encourage preventive measures to address this growing health concern.”

Furthermore, the study highlights that women, especially as they age, face a higher risk of developing arthritis. The risk increases from 10% in the age group above 25 to 33% in the age group above 70. However, the risk of developing arthritis remains relatively consistent for men of all ages.

The findings emphasize the importance of early diagnosis, particularly for younger adults, to enhance the quality of life.

Aditya Kandoi, CEO and founder of Redcliffe Labs, also commented on the findings, stating, “The growing awareness of preventive health checkups is encouraging, but there is still much to be done in combatting chronic autoimmune conditions like arthritis. At Redcliffe Labs, we are dedicated to not only providing affordable and accessible diagnostics but also promoting a cultural shift towards proactive health management. Prevention is the future of healthcare, and we are committed to ensuring that more people can take control of their health before it’s too late.”

As arthritis cases increase and more people become aware of the importance of regular checkups, Redcliffe Labs continues to emphasize the significance of preventive care in addressing the country’s growing health challenges.

5 December 2024: Doctors at Fortis Hospital Noida have successfully performed a complex and high-risk surgery to remove a renal tumour in a 59-year-old woman suffering from Multiple vascular anomalies – a congenital condition where a person has multiple abnormal blood vessel supplying the kidneys. It is a rare condition and occurs in 1 in 25,000 cases.

In normal cases, a kidney has one artery, one vein and one ureter, but in this particular case, the patient was born with 4 renal arteries and 2 ureters. Extracting the tumour from the lower part of her left kidney by clamping multiple veins and arteries was a difficult task. However, the team of doctors led by Dr Piyush Varshney – Director, Urology & Kidney Transplant, Fortis Hospital, Noida conducted the high-risk procedure with the help of Robotic Partial Nephrectomy in mere 90 minutes and the patient was discharged in a stable condition.

The patient was admitted to Fortis Noida with severe pain on the left side of her body, extending from the bottom of the rib cage to the hips. An ultrasound was done, which revealed a tumour on the lower part of her left kidney. Additionally, a CT Urography was also conducted, which revealed multiple abnormal blood vessel. Due to this condition, it was difficult to dissect the blood vessels, tie them separately and cut the tumor, without blood loss. To address the complexity of the case, the team opted for a robot-assisted partial nephrectomy, which provided a 10 times magnified view of the blood vessels and allowed for meticulous dissection and tumour removal.

Giving details of the case, Dr Piyush Varshney – Director, Urology & Kidney Transplant, Fortis Hospital, Noida said, “The surgery was challenging due to the complexity of identifying all the major vessels supplying blood to the kidney, dissecting them without causing injury, and clamping each and every artery and veins separately to remove the kidney tumour without blood loss. However, with the help of Robot-assisted partial nephrectomy, we could successfully remove the tumour without damaging any surrounding tissues or blood vessels. If the tumour was not removed on time, it could have ruptured any time leading to severe bleeding. The problem with such a tumour is that they are composed of fat and blood vessels and has no protective covering. Therefore, a small injury can lead to rupture and the patient may bleed profusely, leading to sudden fall of blood pressure.”

Mohit Singh, Zonal Director, Fortis Hospital, Noida said, “It was a challenging case and, in such cases, it is very important to consult a multi-specialty hospital which is well equipped with the best medical facilities. We have a comprehensive robot-aided surgical program at Fortis Noida, with the specialized team of doctors.”

– Dr. Ankit Shah, Consultant – Surgical Oncology, HCG Cancer Centre, Vadodara

Health issues often present themselves in ways that are easy to dismiss, yet they sometimes hold clues to more significant concerns. Repeated urinary tract infections (UTIs) are one such case—often brushed off as common and treatable. However, for some individuals, recurrent UTIs may point to deeper health issues, including potential signs of bladder cancer. Understanding the connection between frequent UTIs and bladder health can help individuals take proactive steps for timely intervention and better health outcomes.

The Link Between Frequent UTIs and Bladder Health
Recurrent UTIs can be uncomfortable and inconvenient, but they may also indicate changes within the bladder. While the majority of UTIs are not related to cancer, repeated infections can sometimes serve as a red flag. Persistent UTIs may reflect inflammation or abnormal cell growth in the bladder, which are issues that deserve attention.

Symptoms to Watch For
Symptoms associated with UTIs are often easy to recognize. Here are a few that may be cause for further investigation if they keep recurring:
• A strong, persistent urge to urinate
• Burning sensation during urination
• Cloudy or strong-smelling urine
• Pelvic or lower abdominal pain

If these symptoms persist despite antibiotic treatment, it’s wise to seek a medical evaluation. Consistent symptoms after treatment could indicate something beyond typical UTI issues, and a healthcare professional can provide necessary guidance.

Risk Factors to Consider
Certain risk factors increase the likelihood of developing UTIs and other urinary conditions, including bladder cancer. While UTIs affect more women than men, bladder cancer risk is notably higher among men. Some other key risk factors to keep in mind include:
• Smoking: Smokers are three times more likely to develop bladder cancer.
• Occupational Exposure: Jobs involving exposure to chemicals in pesticides, dyes, rubber, metal, and some hairdressing products increase risk.
• Family History: A family history of bladder cancer may heighten individual risk.
• Age and Gender: Bladder cancer is more common in older adults and is diagnosed four times more frequently in men.
Understanding your personal risk profile can be helpful in monitoring symptoms and discussing any concerns with your healthcare provider.

Types of Bladder Cancer
The two main types of bladder cancer vary in their impact and prognosis:
• Transitional Cell Carcinoma: The most common type in the U.S., this cancer type is generally low-grade and not life-threatening, though it can be persistent.
• Squamous Cell Carcinoma: While less common, this high-grade cancer is aggressive and challenging to treat.
Early detection is crucial. Many bladder cancers are diagnosed in early, more manageable stages, making timely intervention essential.

Treatment and Prevention
Treatment for bladder cancer varies depending on the stage and type. Options include –
1. Surgery: Removes tumors directly from the bladder, ideal for early-stage cancers.
2. Chemotherapy: Uses drugs to kill cancer cells, often combined with surgery for better outcomes.
3. Immunotherapy: Boosts the body’s immune system to recognize and fight cancer cells.
4. Radiation Therapy: Targets and destroys cancer cells using high-energy radiation, often for inoperable cases.
5. Intravesical Therapy: Delivers treatment directly into the bladder to reduce side effects on the rest of the body.

For prevention, maintaining bladder health is essential. Good personal hygiene practices, including wiping from front to back and urinating after intercourse, can help prevent UTIs. Staying hydrated, avoiding smoking, and managing exposure to harmful chemicals are also important ways to support bladder health.

Conclusion
Frequent UTIs shouldn’t be taken lightly. While many UTIs are straightforward to treat, persistent infections can sometimes indicate a deeper issue. By staying aware of your symptoms, understanding risk factors, and seeking medical attention when needed, you can take proactive steps to safeguard your bladder health. Prioritizing regular check-ups and open communication with healthcare providers can be key in catching any serious issues early, allowing for more effective management and better overall health.

The Recommended Dietary Allowance (RDA) for protein is approximately 1 gram per kilogram of your body weight. It is important to understand why protein is so important. Made up of amino acids, it is often termed as the chemical building blocks of the body, essential for repairing, building cells, bones and muscles. It also helps to make enzymes, hormones, antibodies and maintain pH balance. Also used as an energy source, it slows chemical reactions while improving appetite, body composition and metabolism, thereby playing a major role in weight management. Thus, it is important to eat your proteins in a way that they can be fully utilised by the body, especially if you are a gym lover and take protein supplements.

Protein pre and post workout
To be able to perform your workout to the best of your potential and to get the best results, you need energy. This should majorly come in the form of protein that will ultimately help in body building and improving your metabolism. Thus, a high protein supplement shake is crucial either before the workout or after it, depending on the timings of your exercise regime. And this high protein is as important as the workout itself since it enables you to balance the diet and calories spent as well as energy required to continue the exercise.

A clean diet
It is a no brainer that one must avoid junk food, white flour, fried food and eat a healthy balanced diet. Cutting down on excessive carbohydrates is also crucial, while sugar should be completely eliminated from the diet. This will ensure that the protein rich supplements that you are consuming will directly help in body building. As the extra carbs and sugar will be ultimately stored by the body, eliminating them will help in supporting your own endeavour towards a healthier life.

Protein first, carbs later
Even when you are excessively hungry, eat the protein part of your meal first, then have a small portion of complex carb/vegetable and healthy fat for balance. This will ensure that your diet is rich in protein, while complex carbs are only eaten once your hunger is satiated.

Choose your protein supplement wisely
While there are multiple protein supplements in the market, ensure that you read through the label carefully to get the best results. Choose high quality supplement with a complete amino acid profile like BigMuscles Nutrition Premium Gold whey or Nitric whey protein which has good 27gm of protein per serving and is available as pre workout and post workout protein supplements that can be mixed with water or milk to make a smoothie. Moreover, ensure that the protein supplement is Vegan and lab tested so that there are no health issues in the future.

Vegetables are still important
While protein does make an important aspect of your diet, vegetables are as important since they contain vitamins, minerals and other necessary nutrients. Although needed in small quantities, these nutrients will balance your diet. A bowl of vegetable is all you need for lunch and dinner. Seasonal vegetables are good too, and make sure that you eat a variety of them to get everything that your body requires

By Dr.Harshavardhan BR, Consulting Orthopedician, Ramakrishna Hospital Jayanagar, Bengaluru)

Disc protrusion, often called a slipped or herniated disc, is a common disorder that affects up to 70% of people in the 30- to 60-year-old age range. Usually, an injury, severe strain, or aging-related spontaneous degeneration of the discs are the causes. It is one of the main causes of leg, back, and neck pain, this ailment is more common in men than in women.

An intervertebral disc protrudes when a tear in its more resilient outer layer allows the disc’s soft, gel-like center to press through. Nerve compression may result from this, which could cause limb weakness, tingling, numbness, and radiating pain. The cervical or thoracic spines in the neck or mid-back can also be affected, while the lumbar spine is the most common location.

The discs that lie between vertebrae serve as cushions, enabling motion and flexibility. But when these discs rupture or leak, the outcome is a herniated disc. In India, the condition is frequently associated with bad posture, extended sitting, heavy weight lifting, and an unhealthy lifestyle. Disc protrusions and hernias both result in pressure-induced structural failures, although they impact the body in distinct ways. Whereas hernias usually happen in the abdomen or groin, disc protrusions affect the spine. Though the pain and symptoms may be similar, many illnesses are different medically.

Diagnosing disc protrusion involves reviewing the patient’s medical history, conducting a physical examination, and using imaging tests like X-rays, MRI, or CT scans to assess the severity.

Conservative measures such as rest, activity reduction, pain management (NSAIDs, muscle relaxants), physical therapy, and hot/cold therapy are useful in treating minor disc protrusion. If these therapies are ineffective, more sophisticated options include spinal fusion, laminectomy, or microdiscectomy, which are surgical procedures intended to relieve pressure on nearby nerves and stabilize the spine, or epidural steroid injections, which provide short-term relief.

4th December 2024: Thyrocare, a leading diagnostic and preventive healthcare provider in India, has released a comprehensive research report uncovering critical insights into the prevalence of diabetes and prediabetes across India. The study, which analyzed HbA1c test results from a staggering 1,966,449 adults nationwide undergoing a routine health check up in 2023, highlights alarming trends and regional disparities in the incidence of the disease. Key findings indicate that 49.43% of the tested population exhibited abnormal blood glucose levels, with 22.25% identified as prediabetic and 27.18% as diabetics. These statistics emphasize the growing burden of this metabolic disorder, positioning diabetes as a “pandemic in the making” and calling for urgent action.

Key Highlights of the Study
1. High Prevalence Across Regions
Odisha reported the highest prevalence of both prediabetes and diabetes, while Jammu & Kashmir recorded the lowest levels. This underscores the need for implementation of region-specific health programs to tackle the disparity.

2. Dietary Patterns and Diabetes
The study revealed a striking correlation between dietary habits and diabetes prevalence. States with higher rice consumption showed a greater incidence of diabetes and prediabetes, while states with predominantly wheat-based diets demonstrated lower prevalence rates, highlighting the role of diet in managing disease risk.

3. Gender and Age Trends
○ Males had a significantly higher diabetes prevalence (30.84%) compared to females (23.51%).
○ Prediabetes prevalence remained relatively balanced between genders.
○ The data shows highest diabetic burden in 65+ individuals, with worrying trends showing increasing prevalence in the economically active age group of 36-65 years. Young adults between 18-35 years show higher prevalence of prediabetes than diabetes, indicating a high potential to develop the disease.

4. Socioeconomic and Healthcare Challenges
The study warns of a severe strain on India’s healthcare infrastructure and individual finances, advocating for regular screening and awareness campaigns to mitigate the impact of undiagnosed cases.

5. Screening Insights and Policy Implications
By leveraging HbA1c—a stable and reliable marker for long-term glucose monitoring—the research highlights the importance of routine testing. The findings urge policymakers to implement targeted preventive measures in high-burden regions, emphasizing lifestyle modifications and public health education.

Mr. Rahul Guha, MD & CEO of Thyrocare Technologies Ltd. & President of API Holdings, commented: “This study sheds light on the silent but alarming rise of diabetes and prediabetes in India. With nearly half the tested population exhibiting abnormal glucose levels, it is imperative to prioritize regular testing, mass screening, and early detection. These efforts, combined with education and region-specific interventions, are crucial to curbing this epidemic. The role of diet in disease management cannot be understated, and we hope this research sparks meaningful action in public health policy and promotes a more proactive approach to disease prevention and management.”

Dr. Preet Kaur, Vice President – Lab Operations and Quality at Thyrocare Technologies Ltd. and a co-author of the study, stated, “This research provides a critical lens through which we can view the diabetes epidemic in India. The geographical and dietary trends revealed in this study demonstrate the significant impact of lifestyle on disease prevalence. Our goal with this research is to inspire not only greater public awareness but also stronger data-driven healthcare policies that prioritize early detection and preventive strategies.”

Thyrocare’s findings, published in the scientific journal – Diabetes Research and Clinical Practice, serve as a clarion call to combat diabetes through sustained efforts in education, lifestyle transformation, and universal screening programs.

By Dr.Subrata Debnath

The interplay between contraception and gynecological cancers—specifically cervical, endometrial, and ovarian cancers—has become a pivotal area of research. As women navigate their reproductive health choices, understanding how various contraceptive methods may influence cancer risk and overall gynecological health is crucial. This connection highlights the importance of informed decision-making in contraceptive use and emphasizes the need for continuous research to better understand these impacts on women’s health.
Hormonal Contraceptives

1. Cervical Cancer:
Hormonal contraceptives, particularly oral contraceptive pills (OCPs), are associated with an increased risk of cervical cancer, especially in women with a history of human papillomavirus (HPV) infection. Research indicates that longer a woman uses oral contraceptives, the greater the increase in her risk of cervical cancer,as hormonal changes may encourage the persistence of HPV infections. However, the risk of cervical cancer has been found to decline over time after women stop using oral contraceptives.
Prevention and Screening: Regular Pap smears are vital for early detection, and the HPV vaccine significantly reduces the risk of cervical cancer by preventing infections, highlighting the importance of preventive healthcare.

2. Endometrial Cancer:
Women who have ever used oral contraceptives have a lower risk of endometrial cancer than women who have never used oral contraceptives. Risk is reduced by at least 30%, with a greater risk reduction the longer oral contraceptives were used (. The protective effect persists for many years after a woman stops using oral contraceptives . A Study found that the risk reduction was especially pronounced in long-time users of oral contraceptives who were smokers, had obesity, or exercised rarely . This protective effect stems from the stabilization of estrogen levels, which helps regulate the endometrial lining and reduces the occurrence of endometrial hyperplasia, a precursor to cancer.
Understanding Endometrial Health: Hormonal balance is key in maintaining a healthy endometrium, and contraceptives play a crucial role in preventing abnormal growths.

3. OvarianCancer:
Hormonal contraceptives also appear to lower the risk of ovarian cancer, with studies suggesting a reduction of up to 40% or more. The protective effect increases with the duration of use, primarily due to reduced ovulation frequency, which may decrease cellular damage in the ovaries.
Long-Term Benefits: Women considering long-term contraceptive methods can discuss potential benefits regarding ovarian cancer risk with their healthcare providers.

Management and Treatment of Gynecological Cancer
When gynecological cancers are diagnosed, a comprehensive management and treatment approach is essential, tailored to the specific type and stage of cancer:

1. Ovarian Cancer:
Surgery: The primary treatment involves removing the ovaries and uterus (total abdominal hysterectomy) and possibly staging procedures to assess the cancer’s spread.
Chemotherapy: Post-surgery, chemotherapy is typically administered, often using a combination of carboplatin and paclitaxel.
Targeted Therapy: For patients with specific genetic markers, such as BRCA mutations, targeted therapies like PARP inhibitors may be effective.

2. Endometrial Cancer:
Surgery: A total abdominal hysterectomy is the basis of treatment, with the possibility of Lymph node removal & staging .
Radiation Therapy: May required post-surgery to reduce recurrence risk, depending upon certain factors in histopathological report .
Chemotherapy: Administered for advanced ,high grade or recurrent cases to manage the disease and symptoms.

3. Cervical Cancer:
Surgery: Treatment varies by stage, from conization (removal of a cone-shaped cervix section) in early cases to radical hysterectomy for advanced cases.
Radiation Therapy: Frequently combined with chemotherapy for advanced cases to enhance effectiveness.
The Importance of Supportive Care
Supportive care is crucial for enhancing the quality of life and managing treatment side effects:
• Pain Management: Effective pain control strategies ensure comfort during treatment
• Nutritional Support: Tailored dietary plans support recovery and manage side effects
• Psychosocial Support: Access to counseling and support groups addresses emotional impacts, helping patients cope with their journey

Conclusion
The relationship between contraception and gynecological cancer is complex, with hormonal contraceptives presenting both risks and protective benefits. Women need to understand these dynamics to make informed choices about their reproductive health. As research continues to clarify these connections, healthcare providers must prioritize open discussions about contraception, cancer risks, and the importance of regular screenings. By empowering women with knowledge about their health, we can promote healthier choices and potentially reduce the incidence of gynecological cancers.

4 December 2024 – MediBuddy, India’s largest digital healthcare platform, today announced the launch of India Health Care Collaborators (IHCC), a networking platform wherein all stakeholders—insurance companies, intermediaries, and providers—come together to focus on improving access to a fraud-resilient cashless network for primary health care. The platform, named BuddyCare, aims to advance the nation’s ambitious goal of “Insurance for All by 2047” and aligns healthcare delivery with innovation and regulatory advancements such as the forthcoming Insurance Amendment Bill.

BuddyCare serves as a plug-and-play solution for insurers, from comprehensive pre-policy issuance services and real-time risk quantification capabilities to post-policy service delivery for health and wellness. Through strategic partnerships with insurance companies, MediBuddy has developed sophisticated intelligence frameworks for risk management, enabling insurers to seamlessly integrate with fraud-resilient Outpatient Department (OPD) systems. This integrated approach marks a significant shift in how healthcare services are delivered and accessed across the country while enabling tech-driven management of risks for the insurance companies

At the core of this transformative platform is a robust network of healthcare professionals, cutting-edge technological solutions, and an unprecedented collaborative approach. MediBuddy has meticulously onboarded over one lakh plus doctors nationwide, creating a comprehensive healthcare ecosystem that promises seamless, cashless services. It also leverages advanced tools like the ‘Sherlock’ Fraud Detection System to ensure transparency and efficiency in healthcare delivery.

Key Differentiators

MediBuddy distinguishes itself through three core value propositions:
1. Unified Insurance Ecosystem: A first-of-its-kind platform integrating multiple insurance categories—life, health, and wellness—into one seamless solution.
2. Extensive Network Reach: Leveraging a vast network of over 100,000+ healthcare providers delivering services across urban and rural India.
3. Innovative Technology Solutions: Pioneering AI-driven tools and risk management systems that advance healthcare delivery.

Satish Kannan, Co-founder & CEO, MediBuddy, said, “The launch of IHCC represents a pivotal milestone in our journey to redefine healthcare delivery in India. By bringing together innovation, collaboration, and a steadfast commitment to quality, we are laying the groundwork for a future where healthcare is universally accessible, cashless, and seamlessly integrated with insurance. This initiative is not just about addressing today’s challenges; it’s about building a resilient and inclusive ecosystem that supports the health and well-being of every individual, aligning with the national vision of ‘Insurance for All by 2047.

The platform distinguishes itself through a holistic service model that goes beyond traditional insurance offerings. From medical consultations and diagnostics to medicine delivery and concierge support, IHCC provides an end-to-end solution that addresses the multifaceted needs of modern healthcare consumers. Recognising the global nature of healthcare, MediBuddy has strategically expanded its services to support Non-Resident Indian [NRI] customers, demonstrating a forward-thinking approach to inclusive healthcare solutions.

The initiative extends beyond service delivery, with a strong commitment to social impact. Through its CSR division, the company is also implementing nationwide training programs for paramedical professionals, thereby strengthening India’s healthcare infrastructure at the grassroots level. MediBuddy’s approach seamlessly blends technological innovation, strategic partnerships, and a deep understanding of customer needs.

December 4, 2024 – Renowned celebrity cosmetologist Dr. Monica Kapoor, Director of Flawless Cosmetic Clinic and ILACAD Institute, is set to launch new batches for aspiring cosmetologists and facial aesthetics professionals this December. Driven by her vision to empower women and redefine the field of medical cosmetology, Dr. Kapoor is opening doors for individuals to embark on transformative careers in cosmetology and facial aesthetics.

With a stellar track record of training over 90% female students, Dr. Kapoor is on a mission to promote independence and create opportunities for women in the rapidly growing field of medical cosmetology. Through her ILACAD Institute, she equips students with cutting-edge knowledge and practical expertise in advanced techniques, helping them establish thriving careers in a competitive industry.

This December, the institute will host two upcoming batches:

Mumbai: December 8, 2024
Delhi: December 18, 2024

Speaking about her vision, Dr. Monica Kapoor shared, “I believe in the power of education to transform lives. Through these training programs, my goal is to empower women to become self-reliant, confident, and successful professionals. Together, we are shaping a new era in medical cosmetology and facial aesthetics.”

With her extensive experience and dedication to fostering talent, Dr. Kapoor is setting a benchmark in the field. Her courses cover state-of-the-art techniques, including facial contouring, advanced skincare, and aesthetic procedures, preparing students for dynamic and rewarding careers.

Join the Journey to Empowerment
Prospective students are encouraged to enroll early to secure their spot in these highly anticipated programs.

Together with Dr. Kapoor, the next generation of cosmetology professionals is poised to make a lasting impact on the world of beauty and aesthetics.

December 04th, 2024 – M | O | C Cancer Care has achieved a groundbreaking milestone in oncology by successfully discharging its first patient who underwent CAR-T cell therapy for Relapsed Refractory Diffuse Large B-Cell Lymphoma (DLBCL), a type of hematological cancer. This accomplishment places M | O | C among the pioneering community cancer care institutions in India to offer this advanced and life-saving therapy.

The patient, a 60-year-old resident of Thane, was admitted on November 5, 2024, after battling relapsed and refractory lymphoma for over three years. Previous treatments, including immunotherapy, had been unsuccessful. Following CAR-T therapy, the patient experienced no complications and was successfully discharged on November 24, 2024.

What Is CAR-T Therapy?
CAR-T (Chimeric Antigen Receptor T-cell) therapy is a revolutionary advancement in cancer treatment. It involves genetically modifying a patient’s own T-cells to precisely target and destroy cancer cells. By harnessing the immune system’s power, CAR-T therapy provides new hope to patients with aggressive and previously untreatable blood cancers.
This achievement was made possible with the help of ImmunoACT, whose expertise in CAR-T cell manufacturing enabled the delivery of this transformative therap.

A Breakthrough in Oncology Care
This milestone underscores M | O | C’s commitment to pioneering advanced therapies and delivering world-class cancer care. “CAR-T therapy is particularly significant for patients with relapsed and refractory lymphomas, who have limited options after the failure of conventional treatments,” said Dr. Suraj Chiraniya.

Dr. Suraj Chiraniya and Dr. Ashray Kole, Hemato-Oncologists and BMT Specialists at M | O | C, added, “This breakthrough marks the beginning of a new era in oncology care, bringing renewed hope to countless patients and families battling complex blood cancers.”

About M | O | C Cancer Care & Research Centre
M | O | C is a chain of community cancer centers operating in Western India. Equipped with state-of-the-art facilities and an expert team of oncologists, M | O | C leads the way in offering innovative treatments, including CAR-T therapy, to improve patient outcomes.

Key Highlights of the CAR-T Success Story
• Patient Details: 60-year-old male from Thane, Mumbai
• Condition: Relapsed Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
• Treatment Timeline: Admitted on November 5, 2024; discharged on November 24, 2024
• Background: Failed three prior treatment regimens, including immunotherapy
• Outcome: Achieved successful remission post-CAR-T therapy

Looking Ahead
This achievement solidifies Mumbai’s position as a hub for advanced oncology care. M | O | C is proud to lead the way in bringing innovative cancer treatments to private healthcare settings, offering new hope to patients and their families.